Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00929344 · ClinicalTrials.gov registry record · Phase 2
Duloxetine Versus Pregabalin for Alcohol Dependence
A Phase 2 study, sponsored by The Scripps Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT00929344 is a Phase 2 study that has completed, run by The Scripps Research Institute. The registered enrollment target is 150 participants.
The verdict
NCT00929344, a Phase 2 study, has completed, sponsored by The Scripps Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
A 12-week, double-blind, placebo-controlled parallel group study will be conducted with 150 outpatients with alcohol dependence, with random assignment to pregabalin 300 mg/d, duloxetine 40 mg/d, or placebo in conjunction with manual-guided behavioral counseling and follow-up visits 1 week and 3 months post-treatment.
Interventions
- DRUG Placebo
- DRUG Duloxetine
- DRUG Pregabalin
- BEHAVIORAL Standardized behavioral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2009-07 |
| Est. Completion | 2014-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00929344
The ClinicalTrials.gov registry entry for NCT00929344 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Scripps Research Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00929344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00929344 about?
NCT00929344 is a clinical study titled "Duloxetine Versus Pregabalin for Alcohol Dependence". A 12-week, double-blind, placebo-controlled parallel group study will be conducted with 150 outpatients with alcohol dependence, with random assignment to pregabalin 300 mg/d, duloxetine 40 mg/d, or placebo in conjunction with manual-guided behavioral counseling and follow-up visits 1 week and 3 mon...
What is the current status of trial NCT00929344?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2009-07. Estimated completion is 2014-10.
What interventions are being tested in trial NCT00929344?
The interventions under investigation include: Placebo (DRUG), Duloxetine (DRUG), Pregabalin (DRUG), Standardized behavioral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00929344?
This trial is sponsored by The Scripps Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.